170 related articles for article (PubMed ID: 19969318)
21. PU box-binding transcription factors and a POU domain protein cooperate in the Epstein-Barr virus (EBV) nuclear antigen 2-induced transactivation of the EBV latent membrane protein 1 promoter.
Sjöblom A; Jansson A; Yang W; Laín S; Nilsson T; Rymo L
J Gen Virol; 1995 Nov; 76 ( Pt 11)():2679-92. PubMed ID: 7595375
[TBL] [Abstract][Full Text] [Related]
22. EBF1 binds to EBNA2 and promotes the assembly of EBNA2 chromatin complexes in B cells.
Glaser LV; Rieger S; Thumann S; Beer S; Kuklik-Roos C; Martin DE; Maier KC; Harth-Hertle ML; Grüning B; Backofen R; Krebs S; Blum H; Zimmer R; Erhard F; Kempkes B
PLoS Pathog; 2017 Oct; 13(10):e1006664. PubMed ID: 28968461
[TBL] [Abstract][Full Text] [Related]
23. Epstein-Barr virus nuclear antigen 3A partially coincides with EBNA3C genome-wide and is tethered to DNA through BATF complexes.
Schmidt SC; Jiang S; Zhou H; Willox B; Holthaus AM; Kharchenko PV; Johannsen EC; Kieff E; Zhao B
Proc Natl Acad Sci U S A; 2015 Jan; 112(2):554-9. PubMed ID: 25540416
[TBL] [Abstract][Full Text] [Related]
24. BS69/ZMYND11 C-Terminal Domains Bind and Inhibit EBNA2.
Harter MR; Liu CD; Shen CL; Gonzalez-Hurtado E; Zhang ZM; Xu M; Martinez E; Peng CW; Song J
PLoS Pathog; 2016 Feb; 12(2):e1005414. PubMed ID: 26845565
[TBL] [Abstract][Full Text] [Related]
25. The amino-terminal domains of Epstein-Barr virus nuclear proteins 3A, 3B, and 3C interact with RBPJ(kappa).
Robertson ES; Lin J; Kieff E
J Virol; 1996 May; 70(5):3068-74. PubMed ID: 8627785
[TBL] [Abstract][Full Text] [Related]
26. Epstein-Barr virus-derived EBNA2 regulates STAT3 activation.
Muromoto R; Ikeda O; Okabe K; Togi S; Kamitani S; Fujimuro M; Harada S; Oritani K; Matsuda T
Biochem Biophys Res Commun; 2009 Jan; 378(3):439-43. PubMed ID: 19032945
[TBL] [Abstract][Full Text] [Related]
27. Activated Notch1 modulates gene expression in B cells similarly to Epstein-Barr viral nuclear antigen 2.
Strobl LJ; Höfelmayr H; Marschall G; Brielmeier M; Bornkamm GW; Zimber-Strobl U
J Virol; 2000 Feb; 74(4):1727-35. PubMed ID: 10644343
[TBL] [Abstract][Full Text] [Related]
28. The CR4 region of EBNA2 confers viability of Epstein-Barr virus-transformed B cells by CBF1-independent signalling.
Grabusic K; Maier S; Hartmann A; Mantik A; Hammerschmidt W; Kempkes B
J Gen Virol; 2006 Nov; 87(Pt 11):3169-3176. PubMed ID: 17030849
[TBL] [Abstract][Full Text] [Related]
29. Epstein-Barr virus EBNA3A and EBNA3C proteins both repress RBP-J kappa-EBNA2-activated transcription by inhibiting the binding of RBP-J kappa to DNA.
Waltzer L; Perricaudet M; Sergeant A; Manet E
J Virol; 1996 Sep; 70(9):5909-15. PubMed ID: 8709211
[TBL] [Abstract][Full Text] [Related]
30. An ATF/CRE element mediates both EBNA2-dependent and EBNA2-independent activation of the Epstein-Barr virus LMP1 gene promoter.
Sjöblom A; Yang W; Palmqvist L; Jansson A; Rymo L
J Virol; 1998 Feb; 72(2):1365-76. PubMed ID: 9445037
[TBL] [Abstract][Full Text] [Related]
31. Both Epstein-Barr viral nuclear antigen 2 (EBNA2) and activated Notch1 transactivate genes by interacting with the cellular protein RBP-J kappa.
Strobl LJ; Höfelmayr H; Stein C; Marschall G; Brielmeier M; Laux G; Bornkamm GW; Zimber-Strobl U
Immunobiology; 1997 Dec; 198(1-3):299-306. PubMed ID: 9442401
[TBL] [Abstract][Full Text] [Related]
32. The Epstein-Barr virus EBNA-LP protein preferentially coactivates EBNA2-mediated stimulation of latent membrane proteins expressed from the viral divergent promoter.
Peng R; Moses SC; Tan J; Kremmer E; Ling PD
J Virol; 2005 Apr; 79(7):4492-505. PubMed ID: 15767449
[TBL] [Abstract][Full Text] [Related]
33. Characterization of the CBF2 binding site within the Epstein-Barr virus latency C promoter and its role in modulating EBNA2-mediated transactivation.
Fuentes-Pananá EM; Ling PD
J Virol; 1998 Jan; 72(1):693-700. PubMed ID: 9420275
[TBL] [Abstract][Full Text] [Related]
34. Latent membrane protein 1 of Epstein-Barr virus induces CD83 by the NF-kappaB signaling pathway.
Dudziak D; Kieser A; Dirmeier U; Nimmerjahn F; Berchtold S; Steinkasserer A; Marschall G; Hammerschmidt W; Laux G; Bornkamm GW
J Virol; 2003 Aug; 77(15):8290-8. PubMed ID: 12857898
[TBL] [Abstract][Full Text] [Related]
35. Increased association between Epstein-Barr virus EBNA2 from type 2 strains and the transcriptional repressor BS69 restricts EBNA2 activity.
Ponnusamy R; Khatri R; Correia PB; Wood CD; Mancini EJ; Farrell PJ; West MJ
PLoS Pathog; 2019 Jul; 15(7):e1007458. PubMed ID: 31283782
[TBL] [Abstract][Full Text] [Related]
36. Latency pattern of Epstein-Barr virus and methylation status in Epstein-Barr virus-associated hemophagocytic syndrome.
Yoshioka M; Kikuta H; Ishiguro N; Endo R; Kobayashi K
J Med Virol; 2003 Jul; 70(3):410-9. PubMed ID: 12767005
[TBL] [Abstract][Full Text] [Related]
37. Hsp72 up-regulates Epstein-Barr virus EBNALP coactivation with EBNA2.
Peng CW; Zhao B; Chen HC; Chou ML; Lai CY; Lin SZ; Hsu HY; Kieff E
Blood; 2007 Jun; 109(12):5447-54. PubMed ID: 17341665
[TBL] [Abstract][Full Text] [Related]
38. Differential hyperacetylation of histones H3 and H4 upon promoter-specific recruitment of EBNA2 in Epstein-Barr virus chromatin.
Alazard N; Gruffat H; Hiriart E; Sergeant A; Manet E
J Virol; 2003 Jul; 77(14):8166-72. PubMed ID: 12829856
[TBL] [Abstract][Full Text] [Related]
39. Mediation of Epstein-Barr virus EBNA2 transactivation by recombination signal-binding protein J kappa.
Henkel T; Ling PD; Hayward SD; Peterson MG
Science; 1994 Jul; 265(5168):92-5. PubMed ID: 8016657
[TBL] [Abstract][Full Text] [Related]
40. Interleukin-21 regulates expression of key Epstein-Barr virus oncoproteins, EBNA2 and LMP1, in infected human B cells.
Konforte D; Simard N; Paige CJ
Virology; 2008 Apr; 374(1):100-13. PubMed ID: 18222514
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
